Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (411-420 of 551) with videos related to

Pageof 56
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Scientific Reports|November 3, 2016
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in TaiwanXifeng Wu, Chi Pang Wen, Yuanqing Ye, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of the National Cancer Institute|June 29, 2007
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention TrialCarol M Moinpour, Amy K Darke, Gary W Donaldson, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Scientific Reports|April 7, 2020
Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in TaiwanXifeng Wu, Chi Pang Wen, Yuanqing Ye, et al.
JCO Precision Oncology|May 7, 2019
Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced MalignanciesShumei Kato, Ryosuke Okamura, Manvita Mareboina, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodulesGiulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2016
Leveraging premalignant biology for immune-based cancer preventionAvrum Spira, Mary L Disis, John T Schiller, et al.
Pageof 56

Showing results (411-420 of 551) with videos related to

Sort By:
Pageof 56
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Scientific Reports|November 3, 2016
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in TaiwanXifeng Wu, Chi Pang Wen, Yuanqing Ye, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of the National Cancer Institute|June 29, 2007
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention TrialCarol M Moinpour, Amy K Darke, Gary W Donaldson, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Scientific Reports|April 7, 2020
Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in TaiwanXifeng Wu, Chi Pang Wen, Yuanqing Ye, et al.
JCO Precision Oncology|May 7, 2019
Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced MalignanciesShumei Kato, Ryosuke Okamura, Manvita Mareboina, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodulesGiulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2016
Leveraging premalignant biology for immune-based cancer preventionAvrum Spira, Mary L Disis, John T Schiller, et al.
Pageof 56